PH.D./ M.PHIL. SUPERVISION

Latest News  


Faculty Name Guide For Name of the Scholar Title of the Dissertation/ Thesis Status Completion Year Attachements
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Abhishek Chanchal Synergistic effect of nanoparticles and their payload on the DNA damage in Cancer Therapy Complete 2010 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Md Najmul Islam Pharmacodynamics of systemically administered pH sensitive biopolymeric nanoparticles carrying Doxorubicin for cancer therapeutics Complete 2013 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Ramendra Pati Pandey Understanding the immune response and oxidative stress by secretory proteins of Mycobacterium tuberculosis encapsulated in chitosan nanoparticles in Murine mode Complete 2013 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Bahadur Singh Gurjar Design and use of diagostic approaches including nanoparticles in immunological investigations of haemolytic uremic syndrome Complete 2016 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Vijay Kumar Design and Development of pH Responsive Chitosan and Glycol Chitosan nanoparticles to Ameliorate Experimental Inflammatory Arthritis in Rat Model Complete 2017 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Ankita Leekha Overcpming Cisplatin resistance in Ovarian cancer Complete 2017 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Sweta Pandey Design and Development of multifunctional bioceramic nanoparticles for synergistic targeting to rheumatoid arthritis Complete 2018 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Imran Moin Metabolic pathways altered by Etoposide Loaded Gelatin nanoparticles in breast cancer: Assessing ROS induced Apoptosis or Necroptosis and in-vivo tumor regression’ Complete 2019 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Aakriti Tyagi “Bio-evaluation of metabolic activities by altering the core in Quantum Dots (QDs) against Hepatocellular carcinoma: in vitro mechanistic studies and in vivo tumor inhibition” Complete 2019 No
Prof. ANITA KAMRA VERMA
(ZOOLOGY)
Ph. D. Disha Mittal Redox-resetting of Cisplatin-resistant ovarian cancer cells by Cisplatin encapsulated Nanostructured-Lipid Carriers (CisNLC); in vivo Pharmacokinetics and Toxicity Complete 2021 No
SiteLock